Back to results
CompletedPhase 3

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Site Reference ID/Investigator# 50065

Birmingham, Alabama, United States

+82 additional locations

View on ClinicalTrials.gov
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease — TrialFind